Previous studies have shown that the phosphoinositide 3-kinase AKT mammalian target of rapamycin (PI3K-AKT-mTOR) signaling pathway exhibits a vital role in the pathogenesis of PAAD and is highly upregulated in pancreatic tumor [47]. The gene discussed is AKT1; the disease is pancreatic neoplasm.